Acticor Biotech is a startup based in France, most recent round Series-c-plus, 4 tracked investors.
Based in France, Acticor Biotech is a startup. Its most recent tracked round is Series-c-plus. Brouky records 4 investors associated with the company.
Acticor Biotech is a clinical-stage biotechnology company developing glenzocimab, a novel therapeutic agent for the treatment of acute ischemic stroke. Its mission is to improve patient outcomes for this condition.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.